The RESTORE Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema
Makaleler > Tam Makale · 2011
Yazarlar: Cezmi AKKIN, Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E. Lang, Pascale Massin, Reinier O. Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner, Andreas Weichselberger
OPHTHALMOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2011, cilt 118, ss 615-625
DOI: 10.1016/j.ophtha.2011.01.031
Özet
Objective: To demonstrate superiority of ranibizumab 0.5 mg monotherapy or combined with laser over laser alone based on mean average change in best-corrected visual acuity (BCVA) over 12 months in diabetic macular edema (DME).